Disentangling Depression in Women with Diabetes: Evidence for Measure-Dependent Associations with Interleukin-4 and Common Inflammatory Biomarkers - Report - MDSpire
Advertisement
Disentangling Depression in Women with Diabetes: Evidence for Measure-Dependent Associations with Interleukin-4 and Common Inflammatory Biomarkers
Depression and Diabetes in Women: Links to Interleukin-4 and Inflammation
Overview
This pilot study of 38 women with type 2 diabetes, most also living with HIV, explored associations between inflammatory biomarkers and depressive symptoms measured by different scales. Notably, IL-4 showed significant negative correlations with PROMIS measures of depression and anxiety, while hsCRP and IL-6 correlations with depression scales were inconsistent.
Background
Women with type 2 diabetes (T2D) have an increased risk of depression, which is often underrecognized and lacks objective biomarkers. Inflammation is implicated in both depression and T2D, suggesting a biological link. However, depression is heterogeneous and assessed by various scales capturing different symptom dimensions, complicating biomarker associations. Understanding these relationships may improve precision mental health approaches in this population.
Data Highlights
Biomarker
Correlation with PROMIS-Depression
Correlation with PROMIS-Anxiety
Correlation with CES-D
p-value
IL-4
rs = -0.35
rs = -0.37
Not significant
0.034 (Depression), 0.025 (Anxiety)
hsCRP
Positive (not significant)
Not reported
Positive (not significant)
Not significant
IL-6
Positive (not significant)
Not reported
Positive (not significant)
Not significant
IL-8
Not reported
Not reported
Moderate correlation with PROMIS-Sleep (rs=0.39)
0.021
Key Findings
IL-4 levels were significantly negatively correlated with PROMIS-Depression and PROMIS-Anxiety scores, indicating higher IL-4 associated with fewer symptoms.
hsCRP and IL-6 showed positive but non-significant correlations with CES-D depression scores, suggesting inconsistent associations.
IL-8 was moderately positively correlated with PROMIS-Sleep scores, linking inflammation to sleep disturbances.
Associations between inflammatory biomarkers and depression varied depending on the depression measurement tool used.
The study population was predominantly Black and Hispanic women with T2D, many also living with HIV, with moderate systemic inflammation indicated by hsCRP.
Clinical Implications
Clinicians should recognize that inflammatory biomarkers may relate differently to depressive symptoms depending on the assessment tool used. Incorporating multiple inflammatory markers beyond hsCRP and IL-6, such as IL-4, and using multidimensional depression measures may enhance detection and understanding of depression in women with T2D. This approach could inform more tailored mental health interventions in this high-risk group.
Conclusion
This exploratory study highlights that inflammatory biomarker associations with depression in women with T2D are complex and measurement-dependent. Larger studies with repeated measures are needed to clarify these relationships and support precision mental health strategies.
References
MACS/WIHS Combined Cohort Study (MWCCS) Bronx site, 2022-2023 -- Exploring the Relationship Between Depression and Diabetes in Women
